全文获取类型
收费全文 | 7896篇 |
免费 | 569篇 |
国内免费 | 1篇 |
出版年
2023年 | 41篇 |
2022年 | 100篇 |
2021年 | 166篇 |
2020年 | 98篇 |
2019年 | 111篇 |
2018年 | 193篇 |
2017年 | 136篇 |
2016年 | 223篇 |
2015年 | 350篇 |
2014年 | 388篇 |
2013年 | 551篇 |
2012年 | 653篇 |
2011年 | 594篇 |
2010年 | 387篇 |
2009年 | 358篇 |
2008年 | 440篇 |
2007年 | 439篇 |
2006年 | 383篇 |
2005年 | 379篇 |
2004年 | 357篇 |
2003年 | 306篇 |
2002年 | 274篇 |
2001年 | 55篇 |
2000年 | 65篇 |
1999年 | 79篇 |
1998年 | 82篇 |
1997年 | 57篇 |
1996年 | 50篇 |
1995年 | 65篇 |
1994年 | 52篇 |
1993年 | 62篇 |
1992年 | 58篇 |
1991年 | 42篇 |
1990年 | 25篇 |
1989年 | 37篇 |
1988年 | 26篇 |
1987年 | 26篇 |
1986年 | 21篇 |
1985年 | 43篇 |
1984年 | 33篇 |
1983年 | 31篇 |
1982年 | 33篇 |
1981年 | 36篇 |
1980年 | 35篇 |
1979年 | 39篇 |
1978年 | 43篇 |
1977年 | 29篇 |
1976年 | 22篇 |
1974年 | 22篇 |
1973年 | 30篇 |
排序方式: 共有8466条查询结果,搜索用时 15 毫秒
991.
Guo W Schafer S Greaser ML Radke MH Liss M Govindarajan T Maatz H Schulz H Li S Parrish AM Dauksaite V Vakeel P Klaassen S Gerull B Thierfelder L Regitz-Zagrosek V Hacker TA Saupe KW Dec GW Ellinor PT MacRae CA Spallek B Fischer R Perrot A Özcelik C Saar K Hubner N Gotthardt M 《Nature medicine》2012,18(5):766-773
992.
993.
Antinori A Marcotullio S Ammassari A Andreoni M Angarano G Armignacco O Carosi G Cinque P d'Arminio Monforte A Di Perri G Ensoli B Floridia M Galli M Mastroianni C Matteelli A Mazzotta F Moroni M Pal G Puoti M Puro V Rizzardini G Sagnelli E Vella S Vullo V Lazzarin A;Italian HIV Guidelines Working Group 《The new microbiologica》2012,35(2):113-159
994.
Peletto S Lo Presti A Modesto P Cella E Acutis PL Farchi F Ciotti M Zehender G Ciccozzi M 《The new microbiologica》2012,35(2):167-174
Usutu virus is a mosquito-borne virus first isolated from Culex naevei in South Africa in 1959. The first emergence of Usutu virus outside Africa was recorded in Austria. Here, a phylogenetic analysis targeting the E5 and NS5 genes was carried out on the viral strains circulating in Europe. The NS5 gene tree showed two main clades, one of which included the Italian sequences. In the E gene tree all sequences grouped into the same main clade, with sequences from Austria divided into two separate clusters. Only sites under negative selective pressure were found in E and NS5 proteins. The results suggest that Usutu virus circulating in Europe has a degree of genetic diversity higher than expected and that infection may arise from different sources. 相似文献
995.
In April 2009 two specimens of a terrestrial flatworm were collected from under a rock in an orchard at Ciutadella de Menorca on the easternmost Balearic island of Menorca (Spain). Their external morphology suggested that both specimens belonged to the invasive blue planarian Caenoplana coerulea, a species which is native to eastern Australia. Sequence data of a fragment of the mitochondrial cytochrome c oxidase subunit I (COI) and of the entire 18S ribosomal RNA confirm its identification. This is one of the first records of the species in Europe where it has only been found in one locality in the United Kingdom, France and NE Spain. 相似文献
996.
Angiotensin-converting enzyme type 2 (ACE2) has been shown to be an important member of the renin angiotensin system. Previously, we observed that central ACE2 reduces the development of hypertension following chronic angiotensin II (Ang-II) infusion in syn-hACE2 transgenic (SA) mice, in which the human ACE2 transgene is selectively targeted to neurons. To study the physiological consequences of central ACE2 over-expression on cardiac function and cardiac hypertrophy, SA and non-transgenic (NT) mice were infused with Ang-II (600 ng/kg/min, sc) for 14 days, and cardiac function was assessed by echocardiography. Blood pressure (BP), hemodynamic parameters, left ventricle (LV) mass/tibia length, relative ventricle wall thickness (2PW/LVD), cardiomyocyte diameters and collagen deposition were similar (P>0.05) between NT and SA mice during saline infusion. After a 2-week infusion, BP was elevated in NT but not in SA mice. Although ejection fraction and fractional shortening were not altered, Ang-II infusion increased 2PW/LVD compared to saline infusion in NT mice. Interestingly, the 2PW/LVD and LV mass/tibia ratios were significantly lower in SA compared to NT mice at the end of infusion. Moreover, Ang-II infusion significantly increased arterial collagen deposition and cardiomyocytes diameter in NT mice but not in transgenic animals (P<0.05). More importantly, ACE2 over expression significantly reduced the Ang-II-mediated increase in urine norepinephrine levels in SA compared to NT mice. The protective effect of ACE2 appears to involve reductions in Ang-II-mediated hypertension and sympathetic nerve activity. 相似文献
997.
Diana Marklein Ulrike Graab Ivonne Naumann Tiandong Yan Rosalie Ridzewski Frauke Nitzki Albert Rosenberger Kai Dittmann Jürgen Wienands Leszek Wojnowski Simone Fulda Heidi Hahn 《PloS one》2012,7(12)
We searched for a drug capable of sensitization of sarcoma cells to doxorubicin (DOX). We report that the dual PI3K/mTOR inhibitor PI103 enhances the efficacy of DOX in several sarcoma cell lines and interacts with DOX in the induction of apoptosis. PI103 decreased the expression of MDR1 and MRP1, which resulted in DOX accumulation. However, the enhancement of DOX-induced apoptosis was unrelated to DOX accumulation. Neither did it involve inhibition of mTOR. Instead, the combination treatment of DOX plus PI103 activated Bax, the mitochondrial apoptosis pathway, and caspase 3. Caspase 3 activation was also observed in xenografts of sarcoma cells in nude mice upon combination of DOX with the specific PI3K inhibitor GDC-0941. Although the increase in apoptosis did not further impact on tumor growth when compared to the efficient growth inhibition by GDC-0941 alone, these findings suggest that inhibition of PI3K may improve DOX-induced proapoptotic effects in sarcoma. Taken together with similar recent studies of neuroblastoma- and glioblastoma-derived cells, PI3K inhibition seems to be a more general option to sensitize tumor cells to anthracyclines. 相似文献
998.
S Sieh AV Taubenberger SC Rizzi M Sadowski ML Lehman A Rockstroh J An JA Clements CC Nelson DW Hutmacher 《PloS one》2012,7(9):e40217
Biophysical and biochemical properties of the microenvironment regulate cellular responses such as growth, differentiation, morphogenesis and migration in normal and cancer cells. Since two-dimensional (2D) cultures lack the essential characteristics of the native cellular microenvironment, three-dimensional (3D) cultures have been developed to better mimic the natural extracellular matrix. To date, 3D culture systems have relied mostly on collagen and Matrigel™ hydrogels, allowing only limited control over matrix stiffness, proteolytic degradability, and ligand density. In contrast, bioengineered hydrogels allow us to independently tune and systematically investigate the influence of these parameters on cell growth and differentiation. In this study, polyethylene glycol (PEG) hydrogels, functionalized with the Arginine-glycine-aspartic acid (RGD) motifs, common cell-binding motifs in extracellular matrix proteins, and matrix metalloproteinase (MMP) cleavage sites, were characterized regarding their stiffness, diffusive properties, and ability to support growth of androgen-dependent LNCaP prostate cancer cells. We found that the mechanical properties modulated the growth kinetics of LNCaP cells in the PEG hydrogel. At culture periods of 28 days, LNCaP cells underwent morphogenic changes, forming tumor-like structures in 3D culture, with hypoxic and apoptotic cores. We further compared protein and gene expression levels between 3D and 2D cultures upon stimulation with the synthetic androgen R1881. Interestingly, the kinetics of R1881 stimulated androgen receptor (AR) nuclear translocation differed between 2D and 3D cultures when observed by immunofluorescent staining. Furthermore, microarray studies revealed that changes in expression levels of androgen responsive genes upon R1881 treatment differed greatly between 2D and 3D cultures. Taken together, culturing LNCaP cells in the tunable PEG hydrogels reveals differences in the cellular responses to androgen stimulation between the 2D and 3D environments. Therefore, we suggest that the presented 3D culture system represents a powerful tool for high throughput prostate cancer drug testing that recapitulates tumor microenvironment. 相似文献
999.
T Akerström J Crona A Delgado Verdugo LF Starker K Cupisti HS Willenberg WT Knoefel W Saeger A Feller J Ip P Soon M Anlauf PF Alesina KW Schmid M Decaussin P Levillain B Wängberg JL Peix B Robinson J Zedenius M Bäckdahl S Caramuta KA Iwen J Botling P Stålberg JL Kraimps H Dralle P Hellman S Sidhu G Westin H Lehnert MK Walz G Akerström T Carling M Choi RP Lifton P Björklund 《PloS one》2012,7(7):e41926
Background
Aldosterone producing lesions are a common cause of hypertension, but genetic alterations for tumorigenesis have been unclear. Recently, either of two recurrent somatic missense mutations (G151R or L168R) was found in the potassium channel KCNJ5 gene in aldosterone producing adenomas. These mutations alter the channel selectivity filter and result in Na+ conductance and cell depolarization, stimulating aldosterone production and cell proliferation. Because a similar mutation occurs in a Mendelian form of primary aldosteronism, these mutations appear to be sufficient for cell proliferation and aldosterone production. The prevalence and spectrum of KCNJ5 mutations in different entities of adrenocortical lesions remain to be defined.Materials and Methods
The coding region and flanking intronic segments of KCNJ5 were subjected to Sanger DNA sequencing in 351 aldosterone producing lesions, from patients with primary aldosteronism and 130 other adrenocortical lesions. The specimens had been collected from 10 different worldwide referral centers.Results
G151R or L168R somatic mutations were identified in 47% of aldosterone producing adenomas, each with similar frequency. A previously unreported somatic mutation near the selectivity filter, E145Q, was observed twice. Somatic G151R or L168R mutations were also found in 40% of aldosterone producing adenomas associated with marked hyperplasia, but not in specimens with merely unilateral hyperplasia. Mutations were absent in 130 non-aldosterone secreting lesions. KCNJ5 mutations were overrepresented in aldosterone producing adenomas from female compared to male patients (63 vs. 24%). Males with KCNJ5 mutations were significantly younger than those without (45 vs. 54, respectively; p<0.005) and their APAs with KCNJ5 mutations were larger than those without (27.1 mm vs. 17.1 mm; p<0.005).Discussion
Either of two somatic KCNJ5 mutations are highly prevalent and specific for aldosterone producing lesions. These findings provide new insight into the pathogenesis of primary aldosteronism. 相似文献1000.
ML Scalley-Kim BW Hess RL Kelly AR Krostag KH Lustig JS Marken PJ Ovendale AR Posey PJ Smolak JD Taylor CL Wood DL Bienvenue P Probst RA Salmon DS Allison TM Foy CJ Raport 《PloS one》2012,7(8):e43332
Chemokines play a key role in leukocyte recruitment during inflammation and are implicated in the pathogenesis of a number of autoimmune diseases. As such, inhibiting chemokine signaling has been of keen interest for the development of therapeutic agents. This endeavor, however, has been hampered due to complexities in the chemokine system. Many chemokines have been shown to signal through multiple receptors and, conversely, most chemokine receptors bind to more than one chemokine. One approach to overcoming this complexity is to develop a single therapeutic agent that binds and inactivates multiple chemokines, similar to an immune evasion strategy utilized by a number of viruses. Here, we describe the development and characterization of a novel therapeutic antibody that targets a subset of human CC chemokines, specifically CCL3, CCL4, and CCL5, involved in chronic inflammatory diseases. Using a sequential immunization approach, followed by humanization and phage display affinity maturation, a therapeutic antibody was developed that displays high binding affinity towards the three targeted chemokines. In vitro, this antibody potently inhibits chemotaxis and chemokine-mediated signaling through CCR1 and CCR5, primary chemokine receptors for the targeted chemokines. Furthermore, we have demonstrated in vivo efficacy of the antibody in a SCID-hu mouse model of skin leukocyte migration, thus confirming its potential as a novel therapeutic chemokine antagonist. We anticipate that this antibody will have broad therapeutic utility in the treatment of a number of autoimmune diseases due to its ability to simultaneously neutralize multiple chemokines implicated in disease pathogenesis. 相似文献